These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28552050)

  • 1. Readthrough of SCN5A Nonsense Mutations p.R1623X and p.S1812X Questions Gene-therapy in Brugada Syndrome.
    Teng S; Huang J; Gao Z; Hao J; Yang Y; Zhang S; Pu J; Hui R; Wu Y; Fan Z
    Curr Gene Ther; 2017; 17(1):50-58. PubMed ID: 28552050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Readthrough of nonsense mutation W822X in the SCN5A gene can effectively restore expression of cardiac Na+ channels.
    Teng S; Gao L; Paajanen V; Pu J; Fan Z
    Cardiovasc Res; 2009 Aug; 83(3):473-80. PubMed ID: 19377070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Readthrough of nonsense mutation W822X in the SCN5A gene can effectively restore expression of cardiac Na+ channels W822X].
    Zhang JT; Huang J; Teng SY; Wang RR; Zhang YH; Pu JL; Hui RT; Zhang S
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar; 39(3):238-41. PubMed ID: 21609529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Readthrough-Promoting Drugs Gentamicin and PTC124 Fail to Rescue Nav1.5 Function of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Carrying Nonsense Mutations in the Sodium Channel Gene SCN5A.
    Kosmidis G; Veerman CC; Casini S; Verkerk AO; van de Pas S; Bellin M; Wilde AA; Mummery CL; Bezzina CR
    Circ Arrhythm Electrophysiol; 2016 Nov; 9(11):. PubMed ID: 27784737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel SCN5A mutation (Q55X) associated with age-dependent expression of Brugada syndrome presenting as neurally mediated syncope.
    Makita N; Sumitomo N; Watanabe I; Tsutsui H
    Heart Rhythm; 2007 Apr; 4(4):516-9. PubMed ID: 17399644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GPD1L-A306del modifies sodium current in a family carrying the dysfunctional SCN5A-G1661R mutation associated with Brugada syndrome.
    Semino F; Darche FF; Bruehl C; Koenen M; Skladny H; Katus HA; Frey N; Draguhn A; Schweizer PA
    Pflugers Arch; 2024 Feb; 476(2):229-242. PubMed ID: 38036776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further Insights in the Most Common SCN5A Mutation Causing Overlapping Phenotype of Long QT Syndrome, Brugada Syndrome, and Conduction Defect.
    Veltmann C; Barajas-Martinez H; Wolpert C; Borggrefe M; Schimpf R; Pfeiffer R; Cáceres G; Burashnikov E; Antzelevitch C; Hu D
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies.
    Meregalli PG; Tan HL; Probst V; Koopmann TT; Tanck MW; Bhuiyan ZA; Sacher F; Kyndt F; Schott JJ; Albuisson J; Mabo P; Bezzina CR; Le Marec H; Wilde AA
    Heart Rhythm; 2009 Mar; 6(3):341-8. PubMed ID: 19251209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced fast-inactivated state stability of cardiac sodium channels by a novel voltage sensor SCN5A mutation, R1632C, as a cause of atypical Brugada syndrome.
    Nakajima T; Kaneko Y; Saito A; Ota M; Iijima T; Kurabayashi M
    Heart Rhythm; 2015 Nov; 12(11):2296-304. PubMed ID: 26031372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nonsense SCN5A mutation associated with Brugada-type electrocardiogram and intraventricular conduction defects.
    Samani K; Ai T; Towbin JA; Brugada R; Shuraih M; Xi Y; Wu G; Cheng J; Vatta M
    Pacing Clin Electrophysiol; 2009 Sep; 32(9):1231-6. PubMed ID: 19719504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
    Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
    Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel Nav1.5 channel mutation, A551T, associated with Brugada syndrome.
    Chiang KC; Lai LP; Shieh RC
    J Biomed Sci; 2009 Aug; 16(1):76. PubMed ID: 19706159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel SCN5A mutation V1340I in Brugada syndrome augmenting arrhythmias during febrile illness.
    Samani K; Wu G; Ai T; Shuraih M; Mathuria NS; Li Z; Sohma Y; Purevjav E; Xi Y; Towbin JA; Cheng J; Vatta M
    Heart Rhythm; 2009 Sep; 6(9):1318-26. PubMed ID: 19648062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG.
    Turker I; Makiyama T; Vatta M; Itoh H; Ueyama T; Shimizu A; Ai T; Horie M
    PLoS One; 2016; 11(8):e0161872. PubMed ID: 27560382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel
    Micaglio E; Monasky MM; Resta N; Bagnulo R; Ciconte G; Giannelli L; Locati ET; Vicedomini G; Borrelli V; Ghiroldi A; Anastasia L; Benedetti S; Di Resta C; Ferrari M; Pappone C
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations.
    Béziau DM; Barc J; O'Hara T; Le Gloan L; Amarouch MY; Solnon A; Pavin D; Lecointe S; Bouillet P; Gourraud JB; Guicheney P; Denjoy I; Redon R; Mabo P; le Marec H; Loussouarn G; Kyndt F; Schott JJ; Probst V; Baró I
    Basic Res Cardiol; 2014; 109(6):446. PubMed ID: 25341504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically engineered SCN5A mutant pig hearts exhibit conduction defects and arrhythmias.
    Park DS; Cerrone M; Morley G; Vasquez C; Fowler S; Liu N; Bernstein SA; Liu FY; Zhang J; Rogers CS; Priori SG; Chinitz LA; Fishman GI
    J Clin Invest; 2015 Jan; 125(1):403-12. PubMed ID: 25500882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.